A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies

NCT01682473 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: ZSTK474

Sponsor

Zenyaku Kogyo Co., Ltd.